GoHealth Competitors

Equitable (NYSE:EQH) and GoHealth (NASDAQ:GOCO) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Equitable and GoHealth's gross revenue, earnings per share (EPS) and valuation.

Equitable has higher revenue and earnings than GoHealth.

Profitability

This table compares Equitable and GoHealth's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for Equitable and GoHealth, as provided by MarketBeat.

Equitable currently has a consensus price target of $29.20, indicating a potential downside of 8.52%. GoHealth has a consensus price target of $21.2222, indicating a potential upside of 71.15%. Given GoHealth's higher possible upside, analysts clearly believe GoHealth is more favorable than Equitable.

Institutional & Insider Ownership

87.9% of Equitable shares are held by institutional investors. Comparatively, 26.6% of GoHealth shares are held by institutional investors. 0.4% of Equitable shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Equitable beats GoHealth on 4 of the 6 factors compared between the two stocks.

Brown & Brown (NYSE:BRO) and GoHealth (NASDAQ:GOCO) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Brown & Brown and GoHealth's gross revenue, earnings per share (EPS) and valuation.

Brown & Brown has higher revenue and earnings than GoHealth.

Profitability

This table compares Brown & Brown and GoHealth's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for Brown & Brown and GoHealth, as provided by MarketBeat.

Brown & Brown currently has a consensus price target of $48.4444, indicating a potential upside of 3.98%. GoHealth has a consensus price target of $21.2222, indicating a potential upside of 71.15%. Given GoHealth's stronger consensus rating and higher possible upside, analysts clearly believe GoHealth is more favorable than Brown & Brown.

Institutional & Insider Ownership

69.1% of Brown & Brown shares are held by institutional investors. Comparatively, 26.6% of GoHealth shares are held by institutional investors. 17.1% of Brown & Brown shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Brown & Brown beats GoHealth on 6 of the 9 factors compared between the two stocks.

Erie Indemnity (NASDAQ:ERIE) and GoHealth (NASDAQ:GOCO) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Earnings & Valuation

This table compares Erie Indemnity and GoHealth's gross revenue, earnings per share (EPS) and valuation.

Erie Indemnity has higher revenue and earnings than GoHealth.

Profitability

This table compares Erie Indemnity and GoHealth's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and target prices for Erie Indemnity and GoHealth, as provided by MarketBeat.

GoHealth has a consensus price target of $21.2222, indicating a potential upside of 71.15%. Given GoHealth's higher possible upside, analysts clearly believe GoHealth is more favorable than Erie Indemnity.

Institutional & Insider Ownership

35.0% of Erie Indemnity shares are held by institutional investors. Comparatively, 26.6% of GoHealth shares are held by institutional investors. 45.8% of Erie Indemnity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Erie Indemnity beats GoHealth on 7 of the 9 factors compared between the two stocks.

Goosehead Insurance (NASDAQ:GSHD) and GoHealth (NASDAQ:GOCO) are both mid-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for Goosehead Insurance and GoHealth, as provided by MarketBeat.

Goosehead Insurance currently has a consensus price target of $126.00, indicating a potential upside of 5.40%. GoHealth has a consensus price target of $21.2222, indicating a potential upside of 71.15%. Given GoHealth's stronger consensus rating and higher possible upside, analysts clearly believe GoHealth is more favorable than Goosehead Insurance.

Institutional & Insider Ownership

45.2% of Goosehead Insurance shares are held by institutional investors. Comparatively, 26.6% of GoHealth shares are held by institutional investors. 63.4% of Goosehead Insurance shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Goosehead Insurance and GoHealth's gross revenue, earnings per share (EPS) and valuation.

Goosehead Insurance has higher revenue and earnings than GoHealth.

Profitability

This table compares Goosehead Insurance and GoHealth's net margins, return on equity and return on assets.

Summary

Goosehead Insurance beats GoHealth on 5 of the 9 factors compared between the two stocks.

GoHealth (NASDAQ:GOCO) and SelectQuote (NYSE:SLQT) are both mid-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.

Earnings and Valuation

This table compares GoHealth and SelectQuote's revenue, earnings per share (EPS) and valuation.

SelectQuote has higher revenue and earnings than GoHealth.

Institutional and Insider Ownership

26.6% of GoHealth shares are owned by institutional investors. Comparatively, 34.8% of SelectQuote shares are owned by institutional investors. 10.3% of SelectQuote shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares GoHealth and SelectQuote's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for GoHealth and SelectQuote, as provided by MarketBeat.

GoHealth currently has a consensus price target of $21.2222, indicating a potential upside of 71.15%. SelectQuote has a consensus price target of $32.70, indicating a potential upside of 24.95%. Given GoHealth's stronger consensus rating and higher possible upside, analysts plainly believe GoHealth is more favorable than SelectQuote.

GoHealth (NASDAQ:GOCO) and CorVel (NASDAQ:CRVL) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation.

Earnings & Valuation

This table compares GoHealth and CorVel's revenue, earnings per share and valuation.

CorVel has higher revenue and earnings than GoHealth.

Insider & Institutional Ownership

26.6% of GoHealth shares are owned by institutional investors. Comparatively, 47.9% of CorVel shares are owned by institutional investors. 50.4% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares GoHealth and CorVel's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent recommendations for GoHealth and CorVel, as reported by MarketBeat.

GoHealth currently has a consensus target price of $21.2222, indicating a potential upside of 71.15%. Given GoHealth's higher possible upside, equities research analysts plainly believe GoHealth is more favorable than CorVel.

Summary

CorVel beats GoHealth on 6 of the 8 factors compared between the two stocks.